Ionis Pharmaceuticals (IONS) Tops Q4 EPS by 35c, Revenues Beat; Offers FY20 Revenue Outlook Below Consensus
Go back to Ionis Pharmaceuticals (IONS) Tops Q4 EPS by 35c, Revenues Beat; Offers FY20 Revenue Outlook Below Consensus| (NASDAQ: IONS) | Delayed: 56.00 +0.13 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.87 | 52 Week High | $62.68 | |||
| Open | $55.16 | 52 Week Low | $19.59 | |||
| Day High | $56.22 | P/E | N/A | |||
| Day Low | $55.16 | EPS | $0.00 | |||
| Volume | 208,330 | |||||

